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Substantial progress has been made in China in using traditional Chinese medicine (TCM) to treat acquired immune
deficiency syndrome (AIDS). Our objective was to review the latest developments in TCM treatment of AIDS in
China between 2004 and 2014. We reviewed the content of original articles investigating the efficacy and safety of
TCM for treating AIDS published in Chinese and English language journals. Relevant references from 2004 to 2014
were found using PubMed and the China National Knowledge Infrastructure Database. We found that TCM has
been widely used for treating AIDS and its complications in China. The number of TCM studies has increased,
which indicates efficacy and safety. Measures of efficacy in the reviewed articles included the alleviation of human
immunodeficiency virus (HIV)-related signs and symptoms, improvements in quality of life, improvements in
long-term survival, counteraction of the adverse side effects of antiviral drugs, promotion of immune reconstitution,
and improvement of laboratory results. In sum, the literature indicates that TCM is safe. TCM plays an important role
in the treatment of AIDS. Some studies have attempted to measure the efficacy and safety of TCM for treating
AIDS, but more evidence is needed. Therefore, more research on this topic is required in the future.
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Nations.Introduction
Acquired immune deficiency syndrome (AIDS) is a type
of communicable disease caused by human immunodefi-
ciency virus (HIV) infection [1]. AIDS was first recog-
nized in the early 1980s. By the end of 2014, 36.9 million
[34.3 million-41.4 million] people were living with HIV,
and 1.2 million [980,000–1.6 million] people died from
AIDS-related illnesses [2]. This global tragedy is likely to* Correspondence: drlzbcn@163.com
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control of AIDS, and the development of adequate ther-
apies, is challenging. It will be a herculean and unpre-
dictable task to find an effective cure for the disease.
Fortunately, methods such as community-based inter-
ventions have improved knowledge, attitudes, and practice
outcomes for AIDS [3, 4]. Mortality and morbidity have
been reduced since combination antiretroviral therapy
(cART) was introduced in 1996 [5]; cART has led to a not-
able increase in survival and quality of life (QOL) and has
substantially improved the health status of HIV infected
patients [6, 7].
At present, cART is the most effective treatment strat-
egy for AIDS, and has the advantage of immunohemato-
logic and virologic outcomes. However, the lifelong
medication involved in cART is often limited by drug tox-
icity, poor adherence to therapy, and drug resistance [8].
It is therefore necessary to find new drugs or treatments,
such as complementary and alternative medicine (CAM),istributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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sistance, drug adherence, and treatment tolerability.
CAM has been used worldwide to treat AIDS and its
complications, and includes traditional Chinese medi-
cine (TCM), acupuncture and moxibustion, and qigong.
Some clinical research has demonstrated that TCM is ef-
fective in treating AIDS [9]. Since 2004, there have been
several efforts to explore the use of TCM in AIDS treat-
ment. For example, a national trial has been conducted
in the five major provinces of China to investigate the
effect of TCM on AIDS, and related research has been
funded by the National Special Science and Technology
Program on Major Infectious Diseases [10]. Additionally,
some new modalities for treating AIDS with TCM have
been developed [11].
TCM and Western medicine (WM) use different strat-
egies to treat AIDS. WM theory is mainly based on
physiological structures or anatomy, and conceives the
therapy goal as the elimination or removal of the patho-
gen. TCM emphasizes the holistic nature of the body
and the subjective experiences of patients and practi-
tioners. TCM disorders arise from external pathological
factors or an imbalance of yin and yang, and the therapy
goals are the harmonization of internal function and ex-
ternal natural environmental changes. Thus, the main
goals of WM, especially cART, are to eliminate, dimin-
ish, or suppress the viral load levels in the body and to
improve the immune system. CD4 + T cell counts and
HIV loads are gold standard evaluation criteria for
AIDS therapy as recommended by the World Health
Organization (WHO). In contrast, TCM places less
emphasis on objective laboratory examination results,
such as CD4 + T cell counts and levels of HIV loads,
and focuses more on AIDS patients’ clinical complaints,
such as abnormal symptoms and signs, lower QOL, com-
plications, opportunistic infections, and cART side effects
[12, 13].
In this paper, we summarize the findings of studies on
the efficacy and safety of TCM for treating HIV/AIDS in
the 10 years from 2004 to 2014.
Alleviating HIV-related signs and symptoms
The signs and symptoms of AIDS result from conditions
that do not normally develop in individuals with healthy
immune systems. Patients infected with HIV often com-
plain of many signs and symptoms (such as diarrhea,
fever, fatigue, insomnia, weakness, and weight loss) [14],
especially when using cART to halt disease progression
and prolong the lifespan. These symptoms may lower
patients’ QOL, reduce therapy compliance, and even
lead to the failure of antiviral treatment.
One of the advantages of TCM is that it can alleviate
HIV-related signs and symptoms. At present, there are
two main TCM approaches for this. One targets a singlesymptom and uses a corresponding fixed herbal prepar-
ation or strategy to relieve or ease it. The other aims to
prevent the occurrence of self-reported symptoms by
using fixed-combination herbal preparations combined
with syndrome differentiation.
HIV/AIDS patients often report diarrhea; this has
many potential causes, including intestinal parasites. Xie
Li Kang capsule is a fixed-combination Chinese herbal
hospital preparation with the TCM properties of warming
the mid-section, invigorating the spleen, producing an in-
secticidal action, and relieving diarrhea with astringents.
Its main ingredients include Galla chinensis, Myristica
eragrans, Cortex dictamni, and garlic. In a randomized,
double-blinded, double-dummy, controlled clinical trial
ending in 2011 to test Xie Li Kang capsule on HIV-related
diarrhea [15], the primary efficacy parameters were stool
weight, abnormal stool frequency, and diarrhea question-
naire scores. The results showed that participants taking
Xie Li Kang capsule experienced significantly reduced
stool weight and diarrhea questionnaire scores compared
with the controlled group. There were no significant dif-
ferences in stool frequency.
Yi Ai Kang capsule is a Chinese hospital herbal prepar-
ation that strengthens the spleen, dries damp, invigorates
vital energy, and nourishes blood. Its main ingredients
include Astragalus membranaceus, ginseng, Ligusticum
chuanxiong, Radix Paeoniae alba, and Scutellaria baica-
lensis. It has been used to treat HIV/AIDS in Henan
Province, China, and more than 4,500 people with the
disease take this preparation every day [11]. One cohort
study evaluated the effects of Yi Ai Kang capsule on 379
asymptomatic HIV patients not on cART [16]. The results
suggested that the treatment was effective in reducing fa-
tigue, shortness of breath, and spontaneous perspiration.
Aining granule tonifies qi, nourishes yin, and invigo-
rates the spleen; it consists of Radix Astragali mongolici,
Fructus lycii, Panax notoginseng, Poria cocos, and Radix
et Rhizoma glycyrrhizae. One randomized, double-
blinded, placebo-controlled clinical trial tested Aining
granule plus cART on 100 HIV/AIDS cases [17]. Although
CD4 +T cell counts decreased in both groups after
11 months, CD4 + T counts declined less in the Aining
group than in the control group. The treatment group
showed significant improvement of symptoms such as fa-
tigue, anorexia, nausea, diarrhea, and skin rash. However,
there was no significant difference between the two
groups in viral load after treatment.
Classic clinical TCM treatment based on syndrome
differentiation has been used to treat HIV-related
signs and symptoms. A multicenter, stratified, rando-
mized, parallel-group trial of 164 subjects evaluated
the effects of TCM on clinical symptoms of AIDS
with pulmonary inflammation [18]. A randomized,
stratified sample was divided into two regimens: the
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drome differentiation plus WM routine treatment)
and the WM group (WM routine treatment). The in-
cidence of TCM symptoms at different time points
was analyzed. The findings suggested that integrated
TCM–WM treatment helps to alleviate the clinical symp-
toms of AIDS with pulmonary inflammation.
In summary, Chinese medicine professionals (CMPs)
have used TCM to alleviate HIV-related signs and symp-
toms, and many observations and trials have been re-
ported. However, the quality of this research is not high;
therefore, the effectiveness of TCM for HIV-related signs
and symptoms is still uncertain.
Improving patients’ QOL
QOL has been defined as “an individual’s perception of
their position in life in the context of the culture and
value systems in which they live and in relation to their
goals, expectations, standards and concerns” [19]. QOL
is a multidimensional concept related to physical, psy-
chological, and social functioning. As the QOL of HIV/
AIDS patients is substantially lower than the general
population, it has been a focus of both TCM and WM
research on HIV/AIDS. CMPs believe that TCM is a
convenient, personalized, inexpensive, and effective
healthcare method and may therefore improve the QOL
of HIV/AIDS patients [20]. QOL is often used as an
assessment indicator for comprehensive TCM AIDS
treatments.
Treatment with Chinese herbal medicine based on
TCM syndrome differentiation might improve QOL for
people with AIDS. A prospective TCM study into QOL
in asymptomatic HIV-infected persons was carried out
from June 2009 to December 2010 in China [21]. This
was a randomized, double-blinded, parallel, placebo-
controlled study on 1,200 patients in the asymptomatic
period of HIV infection for 18 months. The WHO QOL-
HIV scale was used to assess QOL at the time points
0 days, 6 months, 12 months, and 18 months. The QOL
of the treatment group increased more than that of the
control group, which suggests that treatment based on
TCM syndrome differentiation can significantly improve
patients’ QOL.
Fixed-combination Chinese herbal hospital prepara-
tions may also improve QOL in people with AIDS.
Aikang capsule contains 21 Chinese herbs, including
Panax quinquefolius, Dioscorea opposita, Astragalus
membranaceus, Poria cocos, Atractylodes macrocephala,
Radix Rehmanniae preparata, Angelica sinensis, Colla
corii asini, Radix Paeoniae alba, and Ophiopogon japoni-
cus; this capsule tonifies qi and activates blood circula-
tion, strengthens the spleen, tonifies the lung, dries
damp, expels wind, and removes dampness. In a ran-
domized, single-blind, parallel, placebo-controlled studyon 102 HIV/AIDS patients not taking cART [22], the
Nottingham Health Profile was used at 0 days, 3 months,
6 months, and 9 months during follow-up. The results
showed that Aikang capsule can mitigate symptoms of
HIV/AIDS patients, such as pain and reduced physical
activity, by replenishing energy and nurturing general
well-being to improve patients’ QOL.
To summarize, QOL has been used as an indicator
to assess TCM treatment for HIV/AIDS in China and
other countries. However, research to date has been
limited and more evidence is needed to confirm TCM’s
effectiveness.
Benefits for long-term survival of AIDS patients
AIDS is still a fatal disease with limited therapeutic
options. Among infectious diseases, HIV/AIDS has
become the leading cause of death in many countries.
Survival is an important prognostic index and can be
used to express the serious lethality of the disease
and to evaluate long-term curative effects [23]. Re-
cently, some CMPs have reported results from studies
of the survival of HIV/AIDS patients treated with
TCM.
In a prospective cohort study, 165 of 385 AIDS pa-
tients used a 16-herb Chinese medicine anonymity for-
mula for 14 days to 9 months [24]. The 8-year survival
rate was 87 % for the treatment group and 34 % for the
non-treatment group. There were no deaths in patients
who used Chinese herbal medicine for 6–9 months, and
none of the survivors experienced any recurrence of
AIDS or any severe adverse events. This suggests that
Chinese herbal medicine might improve the long-term
survival of AIDS patients.
In a 6-year retrospective cohort study [25], 1,666
people living with HIV in Henan province of China were
treated with comprehensive TCM intervention from
2004 to 2010 with 102,591 person-months of follow-up.
Participants received a fixed preparation of Yi Ai Kang
capsules, plus additional TCM treatment according to
each individual patient’s symptoms using syndrome dif-
ferentiation. Overall, 312 (18.7 %) patients died over the
6-year study period. The total mortality rate over the
study period was 3.6 per 100 person-years, which is
lower than the worldwide rate [26]. The authors repor-
ted that TCM increased the survival and lengthened the
lifespan of people living with HIV. Factors such as sex,
age, education, and CD4 + T cell counts correlated with
survival.
The existing research into the effects of TCM treat-
ment on long-term survival of AIDS patients might be
biased toward the null without accounting for selective
bias. In particular, there are no results from randomized,
controlled trials; thus, the effect of TCM on the survival
of HIV/AIDS patient is still uncertain.
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Although cART can reduce the morbidity and mortality
of AIDS, it inevitably has adverse effects. The main ad-
verse effects of antiviral drugs are myelosuppression,
liver dysfunction, digestive discomfort (including diarrhea,
abdominal distension, and pain), anaphylactic reaction,
dyslipidemia, and sleep disorders. Patients in developing
countries have a limited choice of antivirus strategies.
Antiretroviral treatment is lifelong, and therefore demands
good treatment adherence. However, some patients can-
not endure the treatment’s adverse effects or cannot con-
tinue with cART because of other serious diseases. It is
therefore very important to find methods to reduce drug
toxicity or increase tolerance of antiviral drug toxicity.
Research and clinical observations indicate that TCM can
alleviate or improve some adverse effects.
The main ingredients of Wendan granule include Inula
japonica, Pericarpium citri reticulatae, Pinellia ternata,
Atractylodes macrocephala, Semen raphani, Radix codo-
nopsis, and Coptis chinensis. This preparation regulates
stomach qi and reduces phlegm, clears heat and dries
damp, and eliminates vomiting and warms the stom-
ach. A randomized, placebo-controlled trial investigated
the effect of Wendan granule on alleviating gastroin-
testinal symptoms caused by antiretroviral therapy in 100
patients [27]. The incidence of gastrointestinal adverse
symptoms caused by cART in the treatment group was
20.4 %, which was significantly lower than the incidence
of 48.0 % in the placebo group. This study demonstrated
that Wendan granule can reduce the incidence of gastro-
intestinal adverse symptoms caused by cART, and that
TCM treatment can significantly reduce clinical symptoms,
especially mild or moderate symptoms.
Jing yuan kang capsule is an herbal formulation com-
posed of six Chinese herbs; the main ingredients are
ginseng, Rehmannia glutinosa, Angelica sinensis, Herba
Epimedii, Astragalus membranaceus, and Spatholobus
suberectus. It tonifies qi, promotes blood circulation,
strengthens the spleen, and reinforces the kidney. A ran-
domized, double-blinded trial on 116 AIDS patients found
that 6 weeks of systematic administration of Jing yuan
kang capsule had a good therapeutic effect on peripheral
leucopenia in the treatment group compared with the
control group [28].
Danggui Shaoyao San is a famous Chinese herbal for-
mula that nourishes blood, regulates the liver, nourishes
the spleen, disinhibits dampness, and nourishes qi. Its
main ingredients are Angelica sinensis, Radix Paeoniae
alba, Atractylodes macrocephala, Poria cocos, Alisma
orientale, Radix Curcumae, and Hedyotis diffusa. In one
cohort study, a decoction based on Danggui Shaoyao
San was used to treat cART-induced liver dysfunction in
48 patients [29]. The results showed that the decoctioncould counteract cART-induced liver dysfunction evi-
denced by dampening of elevated liver enzyme levels,
and could alleviate symptoms such as abdominal disten-
sion, diarrhea, poor appetite, and hypochondriac pain.
Although there is some evidence that TCM can miti-
gate the adverse effects of cART, research in this field is
still preliminary.Promoting immune reconstitution
HIV infection usually results in immunodeficiency. Im-
mune reconstitution (IR) is observed when the immune
response recovers to normal or near normal levels after
cART or other treatments. This reduces the incidence of
various AIDS-related opportunistic infections and tumors
and reduces mortality and morbidity in AIDS patients. IR
evaluation indexes include the number and functional
recovery of CD4 + T cells, the stability of the immune acti-
vation state, and the restoration of lymph node structure.
In addition to cART, adoptive immune cell therapy, bone
marrow transplantation, and cytokine infusion can benefit
IR [30]. However, not all patients can receive cART or ex-
perience full IR.
The holistic framework of TCM, its use of syndrome
differentiation, and rich lore of herbal medicine treat-
ment, mean that it is uniquely placed to promote IR.
According to TCM theory, the essence of clinical
manifestation is a deficiency of vital qi at the middle-
late stage of AIDS. Therefore, strengthening qi is a
fundamental TCM treatment therapy. Some research
has demonstrated the important role of TCM in IR.
Immune No.2 is a Chinese hospital herbal preparation
that includes Radix Panacis quinquefolii, Astragalus
membranaceus, and Viola yedoensis. It tonifies qi, nour-
ishes yin, and invigorates primordial qi. In a randomized,
double-blinded, placebo-controlled clinical trial, Immune
No.2 was used to promote IR in 233 patients with HIV/
AIDS after cART [31]. The study showed that Immune
No.2 can effectively improve the numbers of CD4 + T
cells, CD45RA and CD45RO antigen counts, and the
main clinical symptoms and signs of patients after cART,
thereby promoting IR.Improvement of laboratory results
The two main goals of AIDS treatment are to eliminate
viral loads and to raise CD4 + T cell counts. These two
indexes have also been adopted in TCM treatment of
AIDS, and a few studies have demonstrated that TCM is
very promising in reducing HIV viral loads, increasing
CD4 + T cell counts, or affecting other immunological
indicators. Compared with the index of HIV viral loads,
the CD4 + T cell count is currently the more popular
measure of efficacy in TCM clinical trials for AIDS
treatment.
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that includes ginseng, Fructus lycii, Radix Trichosanthis,
Viola yedoensis, and Salvia miltiorrhiza. It supplements
qi, nourishes yin, clears heat, and detoxifies. In a ran-
domized, double-blinded, parallel, placebo-controlled
clinical trial, Zhongyan-4 was tested on 72 HIV/AIDS
patients in the early or middle stage of the disease
[32]. The findings suggested that the efficacy of
Zhongyan-4 was superior to that of a placebo in elevating
CD4 +T, CD45RA+, and CD8 + T counts, reducing HIV
virus load, improving clinical symptoms or signs, and in-
creasing body weight. No obvious adverse reactions were
found.
Fuzheng Paidu granule consists of Astragalus membra-
naceus, ginseng, roasted Rhizoma Atractylodis macroce-
phalae, Poria cocos, Pericarpium Citri reticulatae, Fructus
Amomi, Semen coicis, Radix Morindae officinalis, Herba
Cistanche deserticola, Herba Epimedii, Forsythia suspensa,
Angelica sinensis, and Radix et Rhizoma glycyrrhizae. It
tonifies qi, nourishes yin, invigorates the spleen, clears
heat, and detoxifies. A 6-month cohort study of 34 outpa-
tients with HIV/AIDS tested the granule’s effects on regu-
lation of immune activation molecules CD38 and human
leukocyte antigen-D related to CD4 + T and CD8 + T
cells [33]. The results showed that HIV/AIDS patients
exhibited an immune activation profile following treat-
ment. One potential mechanism of action for Fuzheng
Paidu granule may lie in its ability to up-regulate
CD38 and HLA-DR receptor levels on CD4 + T cells,
and down-regulate them on CD8 + T cells, thereby
modulating immune activation of CD4 + T and CD8 +
T cells.
Treatment safety
The combined use of herbal medicines and chemical
medicines is common in clinical practice, since this kind
of combination can not only improve treatment efficacy
but also help to reduce drug dosages and adverse reac-
tions. Herbal medicines and their effective ingredients
probably induce or inhibit the action of drug metabolic
enzymes and cause drug interactions. Therefore, the
interaction between antiviral medicines and herbal medi-
cines is an issue of concern.
Research has demonstrated that some herbal medi-
cines may interact with antiviral drugs [34], which could
interfere with antiviral drug metabolism and change the
antiviral drug concentration [35]. However, clinical re-
ports show that TCM is a relatively safe treatment
method for HIV/AIDS, with only a few studies reporting
minor side effects. There is no clinical research focusing
on the interaction between TCM and antiviral drugs.
Therefore, we suggest that future research on the simul-
taneous use of TCM and cART should pay more atten-
tion to antiviral drug metabolism.Conclusion
Although the discovery of cART has changed the prog-
nosis of HIV-infected patients, and those treated with
cART have a life expectancy similar to that of uninfected
subjects, TCM has been used worldwide to treat AIDS
and its complications.
This review revealed some new aspects of TCM clin-
ical research on AIDS: use of the distinctive features of
TCM to meet clinical demands, a focus on clinical signs
and symptoms, and the use of different research designs
that are methodologically robust. Research has also
examined the pathogenesis, mechanism, efficacy, and
safety of TCM. We believe that additional research will
help to reveal the importance of TCM for treatment of
AIDS.
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